TP53 and invasive carcinoma: Given that the total EEO extract reduced the viability of LS174 cells, which express wild-type p53, we sought to investigate whether its major compounds could impact the proliferation of cells harboring p53 mutations, which are usually associated with the transition from adenoma to invasive carcinoma in CRC [27].